Cargando…

Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates

Insulin balls, localized insulin amyloids formed at subcutaneous insulin-injection sites in patients with diabetes, cause poor glycemic control owing to impairments in insulin absorption. Our previous study has shown that some insulin balls are cytotoxic, but others are not, implying amyloid polymor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Wakako, Yuzu, Keisuke, Lobsiger, Nadine, Nishioka, Hideo, Sato, Hisako, Nagase, Terumasa, Iwaya, Keiichi, Lindgren, Mikael, Zako, Tamotsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994847/
https://www.ncbi.nlm.nih.gov/pubmed/33767265
http://dx.doi.org/10.1038/s41598-021-86001-y
_version_ 1783669841917378560
author Mori, Wakako
Yuzu, Keisuke
Lobsiger, Nadine
Nishioka, Hideo
Sato, Hisako
Nagase, Terumasa
Iwaya, Keiichi
Lindgren, Mikael
Zako, Tamotsu
author_facet Mori, Wakako
Yuzu, Keisuke
Lobsiger, Nadine
Nishioka, Hideo
Sato, Hisako
Nagase, Terumasa
Iwaya, Keiichi
Lindgren, Mikael
Zako, Tamotsu
author_sort Mori, Wakako
collection PubMed
description Insulin balls, localized insulin amyloids formed at subcutaneous insulin-injection sites in patients with diabetes, cause poor glycemic control owing to impairments in insulin absorption. Our previous study has shown that some insulin balls are cytotoxic, but others are not, implying amyloid polymorphism. Interestingly, the patient with toxic insulin balls had been treated with antibiotic minocycline, suggesting a possible relationship between toxicity of insulin balls and minocycline. However, the direct effect of minocycline on the structure and cytotoxicity of the insulin amyloid is still unclear. Herein, we demonstrated that that minocycline at physiological concentrations induced degradation of insulin amyloids formed from human insulin and insulin drug preparations used for diabetes patients. Interestingly, the process involved the initial appearance of the toxic species, which subsequently changed into less-toxic species. It is also shown that the structure of the toxic species was similar to that of sonicated fragments of human insulin amyloids. Our study shed new light on the clarification of the revelation of insulin balls and the development of the insulin analogs for diabetes therapy.
format Online
Article
Text
id pubmed-7994847
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79948472021-03-29 Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates Mori, Wakako Yuzu, Keisuke Lobsiger, Nadine Nishioka, Hideo Sato, Hisako Nagase, Terumasa Iwaya, Keiichi Lindgren, Mikael Zako, Tamotsu Sci Rep Article Insulin balls, localized insulin amyloids formed at subcutaneous insulin-injection sites in patients with diabetes, cause poor glycemic control owing to impairments in insulin absorption. Our previous study has shown that some insulin balls are cytotoxic, but others are not, implying amyloid polymorphism. Interestingly, the patient with toxic insulin balls had been treated with antibiotic minocycline, suggesting a possible relationship between toxicity of insulin balls and minocycline. However, the direct effect of minocycline on the structure and cytotoxicity of the insulin amyloid is still unclear. Herein, we demonstrated that that minocycline at physiological concentrations induced degradation of insulin amyloids formed from human insulin and insulin drug preparations used for diabetes patients. Interestingly, the process involved the initial appearance of the toxic species, which subsequently changed into less-toxic species. It is also shown that the structure of the toxic species was similar to that of sonicated fragments of human insulin amyloids. Our study shed new light on the clarification of the revelation of insulin balls and the development of the insulin analogs for diabetes therapy. Nature Publishing Group UK 2021-03-25 /pmc/articles/PMC7994847/ /pubmed/33767265 http://dx.doi.org/10.1038/s41598-021-86001-y Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Mori, Wakako
Yuzu, Keisuke
Lobsiger, Nadine
Nishioka, Hideo
Sato, Hisako
Nagase, Terumasa
Iwaya, Keiichi
Lindgren, Mikael
Zako, Tamotsu
Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
title Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
title_full Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
title_fullStr Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
title_full_unstemmed Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
title_short Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
title_sort degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994847/
https://www.ncbi.nlm.nih.gov/pubmed/33767265
http://dx.doi.org/10.1038/s41598-021-86001-y
work_keys_str_mv AT moriwakako degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT yuzukeisuke degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT lobsigernadine degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT nishiokahideo degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT satohisako degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT nagaseterumasa degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT iwayakeiichi degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT lindgrenmikael degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates
AT zakotamotsu degradationofinsulinamyloidbyantibioticminocyclineandformationoftoxicintermediates